Primary Job Title Founder Primary Organization 
Mirimus
Gender Male
LinkedIn View on LinkedIn
Greg Hannon is a professor and Senior Group Leader at the Cancer Research UK Cambridge Institute at the University of Cambridge. He is also the Director of Cancer Genomics at the New York Genome Center and an adjunct professor at the Watson School of Biological Sciences at Cold Spring Harbor Laboratory. He received a B.A. in biochemistry and a
Ph.D. in molecular biology from Case Western Reserve University, where he trained in the laboratory of Tim Nilsen. From 1992 to 1995, he was a postdoctoral fellow in the laboratory of David Beach at CSHL, where he explored cell cycle regulation in mammalian cells. In 2000, he shifted his research focus to the emerging field of RNA interference, quickly becoming one of its recognized leaders. His laboratory identified the effector complex of RNAi, known as RISC, and showed that it contained small RNAs, or siRNAs. The origin of these small RNAs was revealed with his discovery of the Dicer enzyme. In 2002, Dr. Hannon accepted a position as a professor at Cold Spring Harbor Laboratory where he continued his studies to reveal that endogenous non-coding RNAs, then known as small temporal RNAs and now as microRNAs, enter the RNAi pathway through Dicer and direct RISC to regulate the expression of endogenous protein coding genes. Dr Hannon’s research was recognized by Science magazine in 2002 as a Breakthrough of the Year and in 2005 by Esquire magazine’s “Genius Issue” as a Breakthrough of the Decade. He assumed his HHMI position in 2005 as a Howard Hughes Medical Institute Professor. In 2013 he received the General Medical Sciences Method to Extend Research in Time (MERIT) Award from the National Institute of Health. The MERIT Award recognizes scientists whose productivity has been superior, acknowledging their past accomplishments and their future creative, innovative research. Upon his 2014 appointment at the CRUK he was awarded a Royal Society Wolfson Professorship. At the CRUK he continues to explore the mechanisms and regulation of RNA interference as well as its applications to cancer. http://www.cruk.cam.ac.uk/research-groups/hannon-group
